Modern Clinical Guidelines for the Management of Patients with Acute Tonsillitis and Pharyngitis

Acute tonsillitis and pharyngitis are common infectious diseases of upper respiratory tract causing significant discomfort and various complications in patients. This article covers all the issues of tonsillitis and pharyngitis etiology, pathogenesis, classification. Modern clinical guidelines focus on optimizing the diagnosis, management, and prevention of these conditions, ensuring high quality of medical care.

Centor, McIsaac, or FeverPAIN scores can be used for differential diagnosis of viral and streptococcal tonsillopharyngitis. Particular attention is given to the management tactics of patients with these diseases, including the antibiotic therapy for streptococcal tonsillitis. Modern clinical guidelines emphasize the need for individual approach for every patient considering their age, concomitant diseases, and infection course aspects. These guidelines implementation in practice can increase the treatment efficacy, reduce the risk of any complications, and improve the quality of life of patients with acute tonsillitis and pharyngitis.

1. Karneeva OV, Daikhes NA, Polyakov DP. Protokoly diagnostiki i lecheniya ostrykh tonzillofaringitov. RMJ. Otorhinolaryngology. 2015;23(6):307–311. (In Russ).

2. Kenealy T. Sore throat. BMJ Clin Evid. 2014;2014:1509.

3. Krajewska J, Krajewski W, Zub K, Zatoński T. COVID-19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol. 2020;277(7):1885–1897. doi: https://doi.org/10.1007/s00405-020-05968-y

4. Pokala U, Potnuru S, Kanapalli S, et al. A Comparative Study on the General and Otolaryngological Manifestations of COVID-19 in the Hospitalized Population of the Telangana Region During the First and Second Waves. Int Arch Otorhinolaryngol. 2024;28(1):e3–e11. doi: https://doi.org/10.1055/s-0043-1777419

5. Grag K, Shubhanshu K. Effect of Covid-19 in Otorhinolaryngology Practice: A Review. Indian J Otolaryngol Head Neck Surg. 2022;74(Suppl 2):2699–2702. doi: https://doi.org/10.1007/ s12070-020-02040-3

6. Kuzmenkov AYu, Trushin IV, Avramenko AA, et al. AMRmap: an online platform for monitoring antibiotic resistance. Clinical Microbiology and Antimicrobial Chemotherapy. 2017;19(2):84–90. (In Russ).

7. Polyakov DP. Current aspects of acute streptococcal tonsillopharyngitis diagnostics in children. Voprosy sovremennoi pediatrii — Current Pediatrics. 2013;12(3):46–51. (In Russ). doi: https://doi.org/10.15690/vsp.v12i3.680

8. Pelucchi C, Grigoryan L, Galeone C, et al. Guideline for the management of acute sore throat. Clin Microbiol Infect. 2012;18 Suppl 1:1–28. doi: https://doi.org/10.1111/j.14690691.2012.03766.x

9. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A Streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86–e102. doi: https://doi.org/10.1093/cid/cis629

10. McIsaac WJ, Goel V, To T, Low DE. The validity of sore throat score in family practice. CMAJ. 2000;163(7):811–815.

11. Yakovlev SV. Strategiya i taktika ratsional’nogo primeneniya antimikrobnykh sredstv v ambulatornoi praktike. Vestnik prakticheskogo vracha. 2016;(1):23–28. (In Russ).

12. Oliver J, Malliya Wadu E, Pierse N, et al. Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis. PLoS Negl Trop Dis. 2018;12(3):e0006335. doi: https://doi.org/10.1371/journal.pntd.0006335

13. Low DE. Non Pneumococcal streptococcal infections, rheumatic fever. In: Goldman’s Cecil Medicine. Goldman L, Schafer AI, eds. 24th edn. Philadelphia: Elsevier Saunders; 2012. Vol. 2. pp. 1823–1829.

14. Choby BA. Diagnosis and treatment of streptococcal pharyngitis. Am Fam Physician. 2009;79(5):383–390.

15. Darmanyan AS. Sovershenstvovanie metodov diagnostiki i lecheniya ostrykh tonzillitov u detei. [dissertation]. Moscow; 2010. 129 p. (In Russ).

16. Boccazzi A, Garotta M, Pontari S, Agostoni CV. Streptococcal tonsillopharyngitis: clinical vs. microbiological diagnosis. Infez Med. 2011;19(2):100–105.

17. Centor RM, Witherspoon JM, Dalton HP, et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239–246. doi: https://doi.org/10.1177/0272989X8100100304

18. McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. Can Med Assoc J. 1998;158(1):75–83.

19. Little P, Hobbs FD, Moore M, et al. Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: randomised controlled trial of PRISM (primary care streptococcal management). BMJ. 2013;347:f5806. doi: https://doi.org/10.1136/bmj.f5806

20. Fine AM, Nizet V, Mandl KD. Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis. Arch Intern Med. 2012;172(11):847–852. doi: https://doi.org/10.1001/archinternmed.2012.950

21. Fornes Vivas R, Robledo Díaz L, Carvajal Roca E, et al. Utility of clinical criteria for the adequate diagnosis of the pharingoamigdalitis in the pediatric emergency service. Rev Esp Salud Publica. 2019;93:e201911061.

22. Thai TN, Dale AP, Ebell MH. Signs and symptoms of Group A versus Non-Group A strep throat: A meta-analysis. Fam Pract. 2018;35(3):231–238. doi: https://doi.org/10.1093/fampra/ cmx072

23. Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016;7(7):CD010502. doi: https://doi.org/10.1002/14651858.CD010502.pub2

24. Stewart EH, Davis B, Clemans-Taylor BL, et al. Rapid antigen group A streptococcus test to diagnose pharyngitis: a systematic review and meta-analysis. PLoS One. 2014;9(11):e111727. doi: https://doi.org/10.1371/journal.pone.0111727

25. Giraldez-Garcia C, Rubio B, Gallegos-Braun JF, et al. Diagnosis and management of acute pharyngitis in a paediatric population: a cost-effectiveness analysis. Eur J Pediatr. 2011;170(8):1059– 1067. doi: https://doi.org/10.1007/s00431-011-1410-0

26. Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR. Principles of appropriate antibiotic use for acute pharyngitis in adults. Ann Intern Med. 2001;134(6):506–508. doi: https://doi.org/10.7326/00034819-134-6-200103200-00018

27. Rospotrebnadzor. Infektsionnaya zabolevaemost’ v Rossiiskoi Federatsii 2015, 2016, 2017, 2018, 2019, 2020. (In Russ). Доступно по: https://www.rospotrebnadzor.ru/activities/statisticalmaterials. Ссылка активна на 06.04.2025.

28. Otvagin IV, Sokolov NS. Current issues of the diagnosis of infections caused by group A Streptococci. Clinical Microbiology and Antimicrobial Chemotherapy. 2011;13(3):223–230. (In Russ).

29. GOST R 53079.42008. Tekhnologii laboratornye klinicheskie. Obespechenie kachestva klinicheskikh laboratornykh issledovanii. Moscow: Standartinform; 2009. 66 p. (In Russ).

30. Wolford RW, Goyal A, Belgam Syed SY, Schaefer TJ. Pharyngitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available online: https://www.ncbi.nlm.nih.gov/books/ NBK519550. Accessed on April 06, 2025.

31. Windfuhr JP, Toepfner N, Steffen G, et al. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. Eur Arch Otorhinolaryngol. 2016;273(4):973–987. doi: https://doi.org/10.1007/s00405-015-3872-6

32. Tatochenko VK. Antibiotikoi khimioterapiya infektsii u detei. Moscow: IPK KontinentPress; 2008. 256 p. (In Russ).

33. Kalra MG, Higgins KE, Perez ED. Common Questions About Streptococcal Pharyngitis. Am Fam Physician. 2016;94(1):24–31.

34. Førsvoll J, Kristoffersen EK, Øymar K. The immunology of the periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome; what can the tonsils reveal. A literature review. Int J Pediatr Otorhinolaryngol. 2019;130:109795. doi: https://doi.org/10.1016/j.ijporl.2019.1097957

35. Artyushkin SA, Eremina NV. Differential diagnosis and rational therapy of upper airway diseases due to viral infections. RMJ. Otorhinolaryngology. 2016;24(4):245– 250. (In Russ).

36. Chiappini E, Regoli M, Bonsignori F, et al. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther. 2011;33(1):48– 58. doi: https://doi.org/10.1016/j.clinthera.2011.02.001

37. Pichichero ME. The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins? Ped Inf Dis J. 1991;10(10 Suppl):S50– S55. doi: https://doi.org/10.1097/00006454-19911000100011

38. Zwart S, Rovers MM, de Melker RA, Hoes AW. Penicillin for acute sore throat in children: randomised, double blind trial. BMJ. 2003;327(7427):1324. doi: https://doi.org/10.1136/bmj.327.7427.1324

39. Sidorenko SV, Yakovlev SV, Spichak TV, et al. Strategy and tactics of the rational use of antimicrobial drugs in outpatient practice. Eurasian clinical guidelines. 2016.

40. Andreeva IV, Stetsyuk OU, Egorova OA. Respiratory tract infections in pediatrics: difficult answers to simple questions. Russian Journal of Woman and Child Health. 2020;3(2):105–111. doi: https://doi.org/10.32364/2618-84302020-3-2-105-111

41. Resolution of the Expert Council “Principles of rational antibiotic therapy of respiratory infections in children. Let’s preserve antibiotics for future generations”. March 31, 2018, Moscow. Pediatrics (Suppl. Consilium Medicum). 2018;(3):10–15. (In Russ). doi: https://doi.org/10.26442/2413-8460_2018.3.1015

42. Stetsyuk OU, Andreeva IV, Egorova OA. Antibiotic resistance of the main ENT pathogens. RMJ. Medical Review. 2019;3(9-2):78–83. (In Russ).]

43. Hocqueloux L, Guinard J, Buret J, et al. Do penicillins really increase the frequency of a rash when given during Epstein-Barr Virus primary infection? Clin Infect Dis. 2013;57(11):1661–1662. doi: https://doi.org/10.1093/cid/cit553

44. Dibek Misirlioglu E, Guvenir H, Ozkaya Parlakay A, et al. Incidence of Antibiotic-Related Rash in Children with Epstein-Barr Virus Infection and Evaluation of the Frequency of Confirmed Antibiotic Hypersensitivity. Int Arch Allergy Immunol. 2018;176(1):33–38. doi: https://doi.org/10.1159/000481988

45. Mahakit P, Vicente JG, Butt DI, et al. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther. 2006;28(1):99– 109. doi: https://doi.org/10.1016/j.clinthera.2006.01.006

46. Munck H, Jørgensen AW, Klug TE. Antibiotics for recurrent acute pharyngo-tonsillitis: systematic review. Eur J Clin Microbiol Infect Dis. 2018;37(7):1221–1230. doi: https://doi.org/10.1007/s10096018-3245-3

47. Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics. 2004;113:866–882. doi: https://doi.org/10.1542/peds.113.4.866

48. Granizo JJ, Giménez MJ, Barberán J, et al. Efficacy of cefditoren in the treatment of upper respiratory tract infections: a pooled analysis of six clinical trials. Rev Esp Quimioter. 2008;21(1):14–21.

49. Pichichero ME, Casey JR. Bacterial eradication rates with shortened courses of 2ndand 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Diagn Microbiol Infect Dis. 2007;59(2):127–130. doi: https://doi.org/10.1016/j.diagmicrobio.2007.04.010

50. Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of allergic patients: a paradigm shift. Diagn Microbiol Infect Dis. 2007;57(3 Suppl):13S–18S. doi: https://doi.org/10.1016/j.diagmicrobio.2006.12.004

51. Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis. 2007;57(3 Suppl):13S–18S. doi: https://doi.org/10.1016/j.diagmicrobio.2006.12.004

52. Atanasković-Marković M, Velicković TC, Gavrović-Jankulović M, et al. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol. 2005;16(4):341–347. doi: https://doi.org/10.1111/j.1399-3038.2005.00280.x

53. Norton AE, Konvinse K, Phillips EJ, Broyles AD. Antibiotic Allergy in Pediatrics. Pediatrics. 2018;141(5):e20172497. doi: https://doi.org/10.1542/peds.2017-2497

54. Mirakian R, Leech SC, Krishna MT, et al. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy. 2015;45(2):300–327. doi: https://doi.org/10.1111/cea.12468

55. Granowitz EV, Brown RB. Antibiotic adverse reactions and drug interactions. Crit Care Clin. 2008;24(2):421–442, xi. doi: https://doi.org/10.1016/j.ccc.2007.12.011

56. Har D, Solensky R. Penicillin and Beta-Lactam Hypersensitivity. Immunol Allergy Clin North Am. 2017;37(4):643–662. doi: https://doi.org/10.1016/j.iac.2017.07.001

57. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and Management of Penicillin Allergy: A Review. JAMA. 2019;321(2):188–199. doi: https://doi.org/10.1001/jama.2018.19283

58. Zagursky RJ, Pichichero ME. Cross-reactivity in β-Lactam Allergy. J Allergy Clin Immunol Pract. 2018;6(1):72–81. doi: https://doi.org/10.1016/j.jaip.2017.08.027

59. Kryukov AI, Kunel’skaya NL, Gurov AV, et al. Farmakoterapiya gnoino-vospalitel’noi patologii LOR-organov: Methodological recommendations of the Moscow City Department of Health. Moscow: Publishing house of the Moscow City Department of Health; 2018. p. 55. (In Russ).]

60. Sidorenko SV. Problemy etiotropnoi terapii vnebol’nichnykh infektsii dykhatel’nykh putei. Consilium Medicum. 2002;4(1):4–9 (In Russ).

61. Altamimi S, Khalil A, Khalaiwi KA, et al. Short-term lategeneration antibiotics versus longer term penicillin for acute streptococcal pharyngitis in children. Cochrane Database Syst Rev. 2012;(8):CD004872. doi: https://doi.org/10.1002/14651858.CD004872.pub3

62. van Driel ML, De Sutter AI, Habraken H, et al. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst Rev. 2016;9(9):CD004406. doi: https://doi.org/10.1002/14651858.CD004406.pub4

63. Waitayangkoon P, Moon SJ, Tirupur Ponnusamy JJ, et al. Long-Term Safety Profiles of Macrolides and Tetracyclines: A Systematic Review and Meta-Analysis. J Clin Pharmacol. 2024;64(2):164–177. doi: https://doi.org/10.1002/jcph.2358

64. Hansen MP, Scott AM, McCullough A, et al. Adverse events in people taking macrolide antibiotics versus placebo for any indication. Cochrane Database Syst Rev. 2019;1(1):CD011825. doi: https://doi.org/10.1002/14651858.CD011825.pub2

65. Shpynev KV, Kretchikova OI, Kretchikov VA, Kozlov RS. Streptococcus pyogenes: Characteristics of the Pathogen, Isolation, Identification and Susceptibility Testing. Clinical Microbiology and Antimicrobial Chemotherapy. 2007;9(2):104–120. (In Russ).

66. Andreeva IV, Stetsiouk ОU, Azovskova ОV, Kozlov RS. Treatment of Acute Tonsillitis/Pharyngitis: Current Guidelines and Russian Local Situation. Clinical Microbiology and Antimicrobial Chemotherapy. 2013;15(3):198–211. (In Russ).

67. Casey JR, Pichichero ME. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis. Clin Infect Dis. 2005;40(12):1748–1755. doi: https://doi.org/10.1086/430307

68. Kaplan EL, Gooch III WM, Notario GF, Craft JC. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). Clin Infect Dis. 2001;32(12):1798–1802. doi: https://doi.org/10.1086/320745

69. Addy LD, Martin MV. Clindamycin and dentistry. Br Dent J. 2005;199(1):23–26. doi: https://doi.org/10.1038/sj.bdj.4812535

70. Bombassaro AM, Wetmore SJ, John MA. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. J Can Dent Assoc. 2001;67(1):20–22.

71. Seppala H, Nissinen A, Jarvinen H, et al. Resistance to erythromycin in group A streptococci. N Engl J Med. 1992;326:292–297. doi: https://doi.org/10.1056/NEJM199201303260503

72. Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2013;2013(11):CD000023. doi: https://doi.org/10.1002/14651858.CD000023.pub4

73. Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat. JAMA. 2005;294(18):2315–2322. doi: https://doi.org/10.1001/jama.294.18.2315

74. Passali D, Volonte M, Passali GS, et al. Efficacy and safety of ketoprofen lysine salt mouthwash versus benzydamine hydrochloride mouthwash in acute pharyngeal inflammation: a randomized, singleblind study. Clin Ther. 2001;23(9):1508–1518. doi: https://doi.org/10.1016/s0149-2918(01)80123-5

75. Bellussi L, Biagini C. Antiphlogistic therapy with ketoptofen lisyne salt vs nimesulide in secretive otitis media, rhinitis, pharyngitis/ tonsillitis/tracheitis. Otorinolaringologia. 1996;46(1):49–57.

76. Sadeghirad B, Siemieniuk RAC, Brignardello-Petersen R, et al. Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials. BMJ. 2017;358:j3887. doi: https://doi.org/10.1136/bmj.j3887

77. de Cassan S, Thompson MJ, Perera R, et al. Corticosteroids as standalone or add-on treatment for sore throat. Cochrane Database Syst Rev. 2020;5(5):CD008268. doi: https://doi.org/10.1002/14651858.CD008268.pub3

78. Rezk E, Nofal YH, Hamzeh A, et al. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst Rev. 2015;2015(11):CD004402. doi: https://doi.org/10.1002/14651858.CD004402.pub3

79. Olympia RP, Khine H, Avner JR. Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children. Arch Pediatr Adolesc Med. 2005;159(3):278–282. doi: https://doi.org/10.1001/archpedi.159.3.278

80. Thomas M, Del Mar C, Glasziou P. How effective are treatments other than antibiotics for acute sore throat? Br J Gen Pract. 2000;50(459):817–820.

81. Okazanie statsionarnoi pomoshchi detyam. Rukovodstvo po lecheniyu naibolee rasprostranennykh boleznei u detei: A pocket reference. 2nd edn. Moscow: World Health Organization; 2013. 452 p. (In Russ).] Доступно по: https://apps.who.int/iris/bitstream/handle/10665/81170/9789244548370_rus.pdf. Ссылка активна на 07.04.2025.

82. Federal’nye klinicheskie rekomendatsii po okazaniyu skoroi meditsinskoi pomoshchi pri ostroi likhoradke u detei. Union of Pediatricians of Russia. Russian Society of Emergency Medical Care. Moscow: Ministry of Health of Russia; 2015. 10 p. (In Russ).]

83. Popovych V, Koshel I, Malofiichuk A, et al. A randomized, open-label, multicenter, comparative study of therapeutic efficacy, safety and tolerability of BNO 1030 extract, containing marshmallow root, chamomile flowers, horsetail herb, walnut leaves, yarrow herb, oak bark, dandelion herb in the treatment of acute nonbacterial tonsillitis in children aged 6 to 18 years. Am J Otolaryngol. 2019;40(2):265–273. doi: https://doi.org/10.1016/j.amjoto.2018.10.012

84. Dronov IA, Geppe NA, Kolosova NG, Velikoretskaya MD. A combination herbal medicine in the treatment of children with recurrent tonsillopharyngitis. Voprosy prakticheskoi pediatrii = Clinical Practice in Pediatrics. 2020;15(4):16–24. (In Russ). doi: https://doi.org/10.20953/1817-7646-2020-4-16-24

85. Vavilova VP, Abramov-Sommariva D, Steindl H, et al. Clinical effectiveness and tolerability of Tonsilgon® N in the treatment of recurrent upper respiratory tract infections in children: a non-interventional study in Russia. RMJ. 2017(5):350–358. (In Russ).

86. Namazova-Baranova LS, Kharit SM, Tuzankina IA, et al. Results of multicenter study of pidotimod for the prophylaxis of acute respiratory infections in frequently ailing children. Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(2):40–44. (In Russ).]

87. Nikiforova GN, Volkova KB. New opportunities therapy of inflammatory diseases of the pharynx. Consilium Medicum. 2015;17(11):103–107. (In Russ).]

88. Degeorge KC, Ring DJ, Dalrymple SN. Treatment of the Common Cold. Am Fam Physician. 2019;100(5):281–289.

89. Pal’chun VT, Luchikhin LA, Kryukov AI. Vospalitel’nye zabolevaniya glotki: Guide for doctors. Moscow: GEOTARMedia; 2012. 288 p. (In Russ).]

90. Kliaritskaia IL, Maksimova EV, Grigorenko EI. Modern aspects of diet therapy in the Russian Federation. Crimean Journal of Internal Diseases. 2018;(2):26–31. (In Russ).

91. Daikhes NA, Davudov KhSh, Shkoda AS, El’kun GB. Ratsional’nyi vybor obezbolivayushchei terapii u bol’nykh posle tonzillektomii. Russian Bulletin of Otorhinolaryngology. 2006;(6):66–68. (In Russ).

92. Jain N, Lansiaux E, Reinis A. Group A streptococcal (GAS) infections amongst children in Europe: Taming the rising tide. New Microbes New Infect. 2022;51:101071. doi: https://doi.org/10.1016/j.nmni.2022.101071.

93. Gregori G, Righi O, Risso P, et al. Reduction of group A betahemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study. Ther Clin Risk Manag. 2016;12:87–92. doi: https://doi.org/10.2147/TCRM.S96134

94. Di Pierro F, Adami T, Rapacioli G, et al. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther. 2013;13(3):339–343. doi: https://doi.org/10.1517/14712598.2013.758711

95. Di Pierro F, Colombo M, Zanvit A, et al. Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children. Drug Healthc Patient Saf. 2014;6:15–20. doi: https://doi.org/10.2147/DHPS.S59665

96. Bitar MA, Saade R. The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children. Int J Pediatr Otorhinolaryngol. 2013;77(5):670–673. doi: https://doi.org/10.1016/j.ijporl.2013.01.009

97. Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. 2010;6(1):5–12. doi: https://doi.org/10.1007/s12519-010-0001-x.

98. SP 3.1.2.3149-13. Profilaktika streptokokkovoi (gruppy A) infektsii: Sanitary and epidemiological rules. Rospotrebnadzor; 2013. (In Russ).]

99. MU 3.1.1885-04. Epidemiologicheskii nadzor i profilaktika streptokokkovoi (gruppy A) infektsii: metodicheskie ukazaniya: Methodological guidelines. Rospotrebnadzor; 2004. (In Russ).